Document is current
Any future updates will be listed below
-
Authors
von Ahnen, Jan Alwin
Gross, Georg
Lull, Christian
Blauth, Mara
Kraemer, Bernhard
Olsavszky, Victor
Leipe, Jan
Schmieder, Astrid https://orcid.org/0000-0002-6421-9699
-
Funding
Funding for this research was provided by:
Novartis Pharma (MAIN457A_FVJE024)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 11 July 2023
Accepted: 22 August 2023
First Online: 28 September 2023
Declarations
:
: Jan Alwin von Ahnen, Georg Gross, Christian Lull, Mara Blauth, and Victor Olsavszky have no conflicts of interest. Astrid Schmieder: research support/clinical trials: Abbvie, Boehringer-Ingelheim, Celgene, Eli Lilly, Janssen-Cilag, LEO Pharma, Merck, Novartis, Pfizer; Scientific advisory board/speakers bureau: Abbvie, Almirall, Hermal, Janssen, LEO, and Novartis, UCB. Jan Leipe: research support/clinical trials: Abbott, Boehringer, Pfizer, Gilead, Novartis; Scientific advisory board/speakers of bureau: Abbvie, Biogen, BMS, Galapagos, Lilly, medac, MSD, Novartis, Roche, Sanofi, UCB.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of the Medical Faculty Mannheim, Heidelberg University (2020-515N-MA).
